CSTL - Castle Biosciences partners with SciBase for diagnostic tests
2025-06-16 17:11:08 ET
More on Castle Biosciences
- Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call Transcript
- Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern
- Castle Biosciences projects $287-$297M revenue for 2025 amid strategic acquisitions and growth initiatives
- Castle Biosciences Non-GAAP EPS of -$0.20 misses by $0.13, revenue of $87.99M beats by $7.61M
- Seeking Alpha’s Quant Rating on Castle Biosciences